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Objective:  Quillaja  saponaria  bark  contains  a  high  percentage  of  triterpene  saponins  and  has  been  used
for centuries  as antiinﬂammatory  and  analgesic  agent  in  Chilean  folk  medicine.
In  the  Present  study  the  anti-inﬂammatory  activities  of the  aqueous  extract  of commercially  partially
puriﬁed  saponin  from  Quillaja  saponaria  Mol.  in in  vivo animal  models.
Methods  & materials::  Aqueous  extract  of the  plant  material  was  prepared  by  cold  maceration.  The  anti-
inﬂammatory  activity  of a commercial  Quillaja  saponaria  Mol.  (QS)  saponin  extract  was  investigated  by
carragenan  induced  mice  paw  edema  model  for  acute  inﬂammation  (Winter,  1962)  [16].
Results:  The  anti-inﬂammatory  activity  was evaluated  by carragenan  in  paw edema  model  in  swiss  albino
mice (18–20  g).  The  anti-inﬂammatory  activity  was  found  to be dose  dependent  in  carragenan  induced
paw  edema.  QS  was  found  to signiﬁcantly  (p <  0.05)  reduce  the  carragenan  induced  mice  paw  edema
(38.59%;  20  mg/kg  bw)  as  compared  to  carragenan  control.  The  percentage  inhibition  of  standard  anti-
inﬂammatory  drug  indomethacin  was  (55%;  10 mg/kg,  bw).
Conclusion:  The  results  of  the  present  study  demonstrate  that  the  aqueous  extract  of  Quillaja  saponaria
saponins  (QS)  possess  signiﬁcant  anti-inﬂammatory  activity.
© 2015  The  Author.  Published  by Elsevier  Ireland  Ltd. This  is  an  open  access  article  under  the CC. Introduction
Inﬂammation is a complex biological response of vascular
issues against aggressive agents such as pathogens, irritants,
r damaged cells. Acute inﬂammation is the initial response
nd is characterized by the increased movement of plasma
nd innate immune system cells, such as neutrophils and
acrophages, from the blood into the injured tissues. The stan-
ard signs of inﬂammation are expressed by increased blood
ow, elevated cellular metabolism, vasodilatation, release of
oluble mediators, extravasation of ﬂuids and cellular inﬂux
1]. Upon the presence of the inﬂammatory agent, cell mem-
ranes induce the activation of phospholipase A2 followed by
elease of arachidonic acid and inﬂammatory mediators such as
ytokines, serotonin, histamine, prostaglandin and leukotrienes
hat increase vascular permeability, thus facilitating the migra-
ion of leukocytes to the site of inﬂammation [2]. Inﬂammation
nduced by carrageenan is acute, nonimmune, well-researched,
nd highly reproducible. Cardinal signs of inﬂammation—edema,
yperalgesia, and erythema—develop immediately following sub-
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cutaneous injection, resulting from action of proinﬂammatory
agents—bradykinin, histamine, tachykinins, complement and reac-
tive oxygen, and nitrogen species.
Many saponins tested have displayed signiﬁcant antinocicep-
tive, anti-inﬂammatory and antipyretic activities possibly due to
their nonglycosidic moiety, the sapogenin, but also many diverse
activities have also been reported such as antiallergic, antifungal,
analgesic and others [3–6]. Moreover a variety of extracts have
proved to be useful in animal models of inﬂammation [7–10].
The bark of Quillaja saponaria Mol., Quillajaceae (“soap bark”,
“Seifenrinde”, “Panama bark”, “Bois de Panama”) has been used
from times immemorial by the Mapuche people, the major ethnic
group of south-central Chile, to wash hair and wool [11] and for the
treatment of toothache and respiratory inﬂammations. The more
or less pure saponins and speciﬁc fractions of the same are widely
used as vaccine adjuvants [12]. The Chilean soapbark tree (Quillaja
saponaria Mol.) grows in a wide range of habitats in the forests and
scrubland of the Mediterranean climate zone of central Chile. In
relation to the traditional use of quillay bark, Mapuche indigenous
people used it as analgesic for the relief toothache and as detergent
agent [13]. This species is well known for its content of triterpene
saponins (between 8.5 and 16.4%) that are widely used in industry,
in personal care products and as vaccine adjuvants. Related triter-
pene glycosides and their aglycones have been shown to possess
rticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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Table 1
Effect of aqueous bark extract of Quillaja saponaria at 1 mg/kg, 5 mg/kg, 10 mg/kg and 20 mg/kg po and indomethacin as compared to carragenan control in carragenan
induced  paw edema model using vernier callipers.
Groups
n = 5 (in mm)
0 hr 30 min 1 hr 2 hr 3 hr 4 hr
Carragenan (1% w/v) 1.8 ± 0.05 3.34 ± 0.06 3.9 ± 0.03 3.99 ± 0.05 3.95 ± 0.06 3.99 ± 0.02
Carragenan + Indomethacin
(10 mg/kg bw)
1.8 ± 0.05 3.0 ± 0.05 2.96 ± 0.07
(24.1%)
2.25 ± 0.04
(43.6%)
2.2 ± 0.06a
(44.3%)
1.8 ± 0.06a
(55%)
Carragenan + Quillaja
saponaria
1 mg/kg bw
1.85 ± 0.26 3.4 ± 0.05 3.5 ± 0.12
(10.25%)
3.30 ± 0.15
(17.29%)
3.25 ± 0.05a
(17.72%)
3.2 ± 0.01a
(19.79%)
Carragenan + Quillaja
saponaria 5 mg/kg bw
1.85 ± 0.12 2.8 ± 0.01 3.3 ± 0.1
(15.38%)
3.25 ± 0.25
(18.54%)
3.2 ± 0.01a
(18.98%)
3.0 ± 0.06a
(24.8%)
Carragenan + Quillaja
saponaria 10 mg/kg bw
1.8 ± 0.06 2.9 ± 0.05 3.25 ± 0.02
(16.66%)
3.28 ± 0.12
(17.79%)
3.05 ± 0.02a
(22.78%)
2.77 ± 0.05a
(30.57%)
Carragenan + Quillaja
saponaria 20 mg/kg bw
1.85 ± 0.01 2.88 ± 0.02 3.2 ± 0.01
(17.94%)
3.25 ± 0.15
(18.54%)
3.0 ± 0.01a
(24.05%)
2.4 ± 0.01a
(40%)
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[alues are expressed as mean ± SD.
a P < 0.05-signiﬁcant compared to carragenan treated group.
nti-inﬂammatory, antiallergic, antiviral, antifungal and cytotoxic
roperties [14].
Paw swelling, or footpad edema, is a convenient method for
ssessing inﬂammatory responses to antigenic challenges and
rritants. Typically, test compounds are assessed for acute anti-
nﬂammatory activity by examining their ability to reduce or
revent the development of carrageenan-induced paw swelling. In
he present study attempts are made to validate the claims of folk-
ore regarding the anti-inﬂammatory activities of this medicinal
lant.
. Methods & materials
.1. Chemicals
Partially puriﬁed Quillaja saponaria Mol. Saponin was commer-
ially obtained from Sigma–Aldrich (99% pure with sapogenin).
arragenan was obtained from Sigma Chemical Co., Indomethacin
Sigma–Aldrich), Sodium chloride (Merck) was purchased from
haulia Chemicals,Midnapore (enlisted supplier). The vernier cal-
ipers was purchased from Precision India Ltd.
.2. Animals
Male Swiss albino mice (18 ± 2 g) were obtained commercially
rom enlisted supplier of Vidyasagar University and maintained in
tandard laboratory conditions. They were given standard labora-
ory diet and water ad libitum. All animal experiments are approved
y the University Animal Ethics Committee, Department of Phys-
ology with Community Health, Vidyasagar University, Paschim
edinipur, India and were in accordance with the guidelines of the
ommittee for the purpose of Control and Supervision of Experi-
ents on Animal (CPCSEA), Government of India.
.3. Aqueous extract
Aqueous extract was prepared by cold maceration. Extract was
ltered and concentrated to dryness by a rotary evaporator.
.4. Acute toxicity studyTo assess the acute toxicity LD50 value of the aqueous extract
as attempted using the up and down method described by Bruce
15].2.5. Acute inﬂammation
Carrageenan-induced rat paw oedema is used widely as a work-
ing model of inﬂammation in the search for new anti-inﬂammatory
drug. The anti inﬂammatory activity of the aqueous extracts of Quil-
laja saponaria Mol. was evaluated by carrageenan-induced rat paw
oedema method [16].
Swiss albino mice (18 ± 2 g) obtained from commercial sup-
pliers were used. Antiinﬂammatory activity was measured using
carrageenan induced rat paw oedema assay. The rats were divided
into 7 groups of 5 animals each (plant extract was dissolved in
sterile distilled water and administered intra peritoneally at dif-
ferent dose levels). Group I was treated with carragenan (1%w/v)
in saline in the subplanter region of the right hind paw. Rats of
Group II were given normal saline and treated as negative control.
Rats in Group III were administered Indomethacin(10 mg/kg, bw)
and considered as standard. Rats from Group IV to Group VII were
given increasing doses of aqueous extracts of Quillaja saponaria
(1 mg/kg, 5 mg/kg, 10 mg/kg, 20 mg/kg bw). Acute paw edema was
induced by injecting 0.1 ml  of 1% (w/v) carrageenan solution, pre-
pared in normal saline. After 1 h, 0.1 ml,  1% carrageenan suspension
in 0.9% NaCl solution was injected into the sub-plantar tissue of the
right hind paw. The linear paw circumference will be measured
at hourly interval for 4 h. The perimeter of paw was  measured by
using vernier callipers. Measurements were taken at 0–4 h after the
administration of the carrageenan.
The anti-inﬂammatory activity was calculated by using the rela-
tion
%inhibition of edema = T − T0
T
× 100
T, Thickness of paw in control group; T0, Thickness of paw edema
in the test compound treated group.
2.6. Statistical analysis
Results of antiinﬂammatory activity were expressed as Mean
increase in paw diameter ± SD. Results were analyzed using one
way ANOVA. Differences were considered as statistically signiﬁcant
at P < 0.05 are compared to control.
3. Results
3.1. Antiinﬂammatory activityThe aqueous extract of Quillaja saponaria Mol. and standard
drug as compared to carragenan control (at 3rd and 4th hour)
in carragenan induced paw edema model using vernier callipers.
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and  some derivatives, J. Pharm. Pharmacol. 63 (5) (2011) 718–724.S. Sarkhel / Toxicolo
queous extract administered at a dose of 20 mg/kg, showed
7.94%, 18.54%, 24.05% and 40% inhibition at 1–4th hour respec-
ively while Indomethacin at a dose of 10 mg/kg po prevented
arragenan induced paw edema with a percentage inhibition of
4.1%, 43.6%,44.4%, 55% at 1–4th hour respectively (Table 1).
. Discussion
Inﬂammation is a part of the complex biological response of
ascular tissues to harmful stimuli, such as pathogens, damaged
ells or irritants. It is characterized by redness, swollen joints,
oint pain, its stiffness and loss of joint function. Inﬂammation
s currently treated by NSAIDs. Unfortunately these drugs cause
ncreased risk of blood clot resulting in heart attacks and strokes.
herefore, the developments of potent anti-inﬂammatory drugs
rom the natural products are now under considerations. Carrage-
an induced acute inﬂammation is one of the most suitable test
rocedure to screen antiinﬂammtory drugs. The time course of
dema development in carragenan induced edema is represented
y a biphasic curve [17]. The ﬁrst phase of inﬂammation occurs
ithin an hour of injection of carragenan which occurs partly due
o trauma of injection and partly due to serotonin and histamine
omponent. Carragenan induced paw edema is sensitive to cycloxy-
enase inhibitors and are used to evaluate the effect of non steroidal
nti-inﬂammatory agents, which primarily inhibit the cycloxyge-
ase involved in prostaglandin synthesis [18]. It plays a major role
n the second phase of anti-inﬂammatory reaction, which is mea-
ured at the 3rd hour. As shown there is a signiﬁcant percentage
nhibition (p < 0.05) of paw edema at the 4th hour (40% at 20 mg/kg,
w). The percentage inhibition of standard anti-inﬂammatory drug
ndomethacin was (55%; 10 mg/kg, bw). Therefore it can be inferred
hat the possible inhibitory effect of aqueous extract of Quillaja
aponaria Mol. in carragenan induced inﬂammation may  be due to
nhibition of cycloxygenase leading to inhibition of prostaglandin
ynthesis.
. Conclusion
The Chilean Soap bark tree (Quillaja saponaria Mol.) is excep-
ionally rich in natural triterpenic saponins. In ancient tradition of
he indigenous Mapuche people of Central Chile, aqueous extracts
f milled bark played an important part in their personal and
edicinal care. Earlier topical anti-inﬂammatory activity of quil-
aic acid from Quillaja saponaria Mol. and some derivatives [19] has
een reported. Antinociceptive activity of Quillaja saponaria Mol.
aponin extract, quallic acid and derivatives in mice has been stud-
ed [20]. This study reports the anti-inﬂammatory activity (in vivo)
f commercial partially puriﬁed Quillaja saponaria Mol saponin in
arragenan induced paw edema model. This study aimed to cor-
oborate the presumed anti-inﬂammatory activity of this plant and
alidate the folklore claims.
[ports 3 (2016) 1–3 3
Acknowledgements
Author is grateful to the Head, Department of Human Physiology
with Community Health, Vidyasagar University for his encour-
agement and support. Author is indebted to UGC  for ﬁnancial
support received in the form of UGC-BSR Start Up grant(S.No:20-
4[17]/2012[BSR] dt 08/03/2013). Author is thankful to all the tribal
informants who have participated in this survey and provided their
valuable knowledge relevant to this work.
References
[1] L. Ferrero-Miliani, O.H. Nielsen, P.S. Andersen, S.E. Girardin, Chronic
inﬂammation: importance of NOD2 and NALP3 in interleukin-1beta
generation, Clin. Exp. Immunol. 147 (2) (2007) 227–235.
[2] M.  Dassoler, M.  Schwanz, F. Busseto, E.A. Moreira, L. Gutierrez, Perﬁl
ﬁtoquímico e ensaiofarmacológico de Averrhoa carambola L. (Oxalidaceae),
Jornal Brasileiro de Fitomedicina 2 (2004) 4–8.
[3] K. Hostettmann, A. Marston, Saponins, Cambridge University Press,
Cambridge, New York, 1995.
[4] J. Milgate, D.C.K. Roberts, The nutritional and biological signiﬁcance of
saponins, Nutr. Res. 15 (1995) 1223–1249.
[5] M.A. Lacaille-Dubois, H. Wagner, A review of the biological and
pharmacologicalactivities of saponins, Phytomedicine 2 (1996) 363–386.
[6] G. Francis, Z. Kerem, H.P.S. Makkar, K. Becker, The biological action of
saponins in animal systems: a review, Br. J. Nutr. 88 (2002) 587–605.
[7] C.A. De La Lastra, I. Villegas, Resveratrol as an anti-inﬂammatory and anti-
ageing agent: mechanism & clinical implications, Mol. Nutr. Food Res. 49 (5)
(2005) 405–430.
[8] Y. Liu, M.  Song, T.M. Che, D. Bravo, J.E. Pettigraw, Anti-inﬂammatory effects of
several plant extracts on porcine alveolar macrophage in vitro, J. Anim. Sci. 90
(8)  (2012) 2774–2783.
[9] K.H. Lee, A.J. Kim, E.M. Choi, Antioxidant and anti-inﬂammatory activity of
pine pollen extract in vitro, Phytother. Res. 23 (1) (2009) 41–48.
10] J.S. Kang, K.H. Lee, M.H. Han, H.  Lee, J.M. Ahn, S.B. Han, K. Lee, S.K. Park, H.M.
Kim, Anti-inﬂammatory activity of methanol extract isolated from stem bark
of  Magnolia kobus, Phytother. Res. 22 (7) (2008) 883–888.
11] K. Kubitzki, The Families and Genera of Vascular Plants, vol. 9, Springer, Berlin
&  Heidelberg, New York, 2007, pp. 407–408.
12] H.X. Sun, Y. Xie, Y.P. Ye, Advances in saponin based adjuvants, Vaccines 27
(12)  (2009) 1787–1796.
13] J. Zin, Weiss C. La Salud Por Medio de Las Plantas Medicinales, 6th ed.,
Editorial Salesiana, Santiago de Chile; 1980, p. 277. (in Spanish).
14] M.R. Roner, J. Sprayberry, M.  Spinks, S. Dhanji, Antiviral activity obtainedfrom
aqueous extracts of the Chilean soap bark tree (Quillaja saponaria Mol.), J.
Genet. Virol. 88 (2007) 275–285.
15] R.D. Bruce, An up and down procedure for acute toxicity testing, Fundam.
Appl. Toxicol. 5 (1995) 151–157.
16] C.A. Winter, E.A. Risley, G.W. Nuss, Carrageenan-induced oedemain the hind
paw of rat as an assay for anti-inﬂammatory activity, Proc. Soc. Exp. Biol. Ther.
111 (1962) 544–547.
17] R. Vinegar, W.  Schreiber, R. Hugo, Biphasic development of carrageenan in
rats, Pharmacol. Exp. Ther. 166 (1969) 96–103.
18] K. Seibert, J.L. Masferrer, Role of inducible cycloxygenase (COX 2) in
inﬂammation, Receptor 4 (1) (1994) 17–23.
19] M.  Rodríguez-Díaz, C. Delporte, B.K. Cassels, P. González, X. Silva, F. León,
Topical anti-inﬂammatory activity of quillaic acid from Quillaja saponaria Mol.20] S. Arrau, C. Delporte, C. Cartagena, M.  Roddriquez-Diaz, P. Gonzalez, X. Silva,
B.K.  Casssels, H.F. Miranda, Antinociceptive activity of Quillaja saponaria Mol.
saponin extract, quallic acid and derivatives in mice, J. Ethnopharmacol. 133
(1) (2011) 164–167.
